Fundraising FoxHatteras Venture Partners — 2014 Investments
3 investments dated 2014 · listed companies and verified rows first · show all
Pelthos Therapeutics is a biopharmaceutical company that develops and commercializes topical treatments for infectious skin conditions and parasitic infestations.
BiotechHealthtechMedical DevicesDurham, US
Mark Schoenfisch(Executive Officer, Director)Nathan Stasko(Executive Officer, Director)
BoardRobert A Ingram(Director)Sean Murphy(Director)W Kent Geer(Director)John W Palmour(Director)
Board seatRobert Ingram· per SEC Form D · $50M raise · filed Mar 2015
Clinverse was a Durham, NC-based fintech company that automated financial management for global clinical trials, including site payments, budgeting, and currency conversion via its ClinPay platform.
Durham, US
Joseph F. Trepanier(Executive Officer)M. Denis Connaghan(Executive Officer, Director)in
BoardJohn Crumpler(Director)inAndy Strayer(Director)Kenneth B. Lee(Director)inNathaniel C. Brinn(Director)
Co-investorsEdison Partners
Lysosomal Therapeutics Inc.
BiotechCambridge, US
Dimitri Krainc(Director)Robert Carpenter(Executive Officer, Director)Cornelis Been(Executive Officer, Director)
BoardSteven Hall(Director)Carole Nuechterlein(Director)inBernard Davitian(Director)
Co-investorsSanofi VenturesAtlas VentureLilly VenturesOmega FundsRoche Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.